XML 17 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 6,266 $ 401,588,570 $ (85,188) $ 60,796 $ (388,182,802) $ 13,387,642
Balance, shares at Dec. 31, 2023 626,654          
Balance, shares at Dec. 31, 2023     2      
Net loss (9,717,542) (9,717,542)
Issuance of common stock upon exercise of restricted options, shares 73          
Stock-based compensation expense 131,929 131,929
Realized and unrealized gains (losses), net, on investments securities (60,796) (60,796)
Issuance of common stock upon exercise of restricted options 1 1
Balance at Jun. 30, 2024 $ 6,267 401,720,499 $ (85,188) (397,900,344) 3,741,234
Balance, shares at Jun. 30, 2024 626,727          
Balance, shares at Jun. 30, 2024     2      
Balance at Mar. 31, 2024 $ 6,267 401,557,890 $ (85,188) 133,101 (393,112,327) 8,499,743
Balance, shares at Mar. 31, 2024 626,727          
Balance, shares at Mar. 31, 2024     2      
Net loss (4,788,017) (4,788,017)
Stock-based compensation expense 162,609 162,609
Realized and unrealized gains (losses), net, on investments securities (133,101) (133,101)
Balance at Jun. 30, 2024 $ 6,267 401,720,499 $ (85,188) (397,900,344) 3,741,234
Balance, shares at Jun. 30, 2024 626,727          
Balance, shares at Jun. 30, 2024     2      
Balance at Mar. 31, 2024 $ 6,267 401,557,890 $ (85,188) 133,101 (393,112,327) 8,499,743
Balance, shares at Mar. 31, 2024 626,727          
Balance, shares at Mar. 31, 2024     2      
Issuance of common stock upon exercise of restricted options, shares 980          
Balance at Jun. 30, 2025 $ 17,175 416,373,961 $ (85,188) (413,646,098) $ 2,659,850
Balance, shares at Jun. 30, 2025 1,717,502          
Balance, shares at Jun. 30, 2025     2     2
Balance at Dec. 31, 2024 $ 9,667 411,122,863 $ (85,188) (406,803,044) $ 4,244,298
Balance, shares at Dec. 31, 2024 966,714          
Balance, shares at Dec. 31, 2024     2     2
Net loss (6,843,054) $ (6,843,054)
Sale of equity through equity financing facilities, net of costs $ 4,895 2,958,843   2,963,738
Sale of equity through equity financing facilities, net of costs, shares 489,485          
Issuance of common stock upon exercise of common stock warrants $ 2,603 1,965,091   1,967,694
Issuance of common stock upon exercise of common stock warrants, shares 260,323          
Issuance of common stock upon exercise of restricted options, shares 980          
Stock-based compensation expense 327,164   327,164
Issuance of common stock upon exercise of restricted options 10   10
Balance at Jun. 30, 2025 $ 17,175 416,373,961 $ (85,188) (413,646,098) $ 2,659,850
Balance, shares at Jun. 30, 2025 1,717,502          
Balance, shares at Jun. 30, 2025     2     2
Balance at Mar. 31, 2025 $ 9,747 411,433,008 $ (85,188) (410,905,539) $ 452,028
Balance, shares at Mar. 31, 2025 974,717          
Balance, shares at Mar. 31, 2025     2      
Net loss (2,740,559) (2,740,559)
Sale of equity through equity financing facilities, net of costs $ 4,815 2,853,231   2,858,046
Sale of equity through equity financing facilities, net of costs, shares 481,482          
Issuance of common stock upon exercise of common stock warrants $ 2,603 1,965,091   1,967,694
Issuance of common stock upon exercise of common stock warrants, shares 260,323          
Issuance of common stock upon exercise of restricted options $ 10   10
Stock-based compensation expense 122,631   122,631
Balance at Jun. 30, 2025 $ 17,175 $ 416,373,961 $ (85,188) $ (413,646,098) $ 2,659,850
Balance, shares at Jun. 30, 2025 1,717,502          
Balance, shares at Jun. 30, 2025     2     2